Stockscreener 앱 받기
4.9544
2.22%
-0.1156
전일 마감가:
$5.07
열려 있는:
$4.97
하루 거래량:
459.88K
Relative Volume:
0.29
시가총액:
$643.02M
수익:
$433.14M
순이익/손실:
$4.95M
주가수익비율:
138.78
EPS:
0.0357
순현금흐름:
$6.55M
1주 성능:
-5.57%
1개월 성능:
+46.67%
6개월 성능:
+75.18%
1년 성능:
+77.05%
1일 변동 폭
$4.915
$5.115
1주일 범위
$4.8609
$5.40
52주 변동 폭
$2.165
$6.71
Organogenesis Holdings Inc Stock (ORGO) Company Profile
명칭
Organogenesis Holdings Inc
전화
781-575-0775
주소
85 DAN ROAD, CANTON, MA
ORGO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ORGO
Organogenesis Holdings Inc
|
4.955 | 643.02M | 433.14M | 4.95M | 6.55M | 0.0357 |
|
ZTS
Zoetis Inc
|
162.77 | 73.33B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.12 | 47.80B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.36 | 46.89B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.34 | 18.62B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
131.53 | 13.99B | 612.78M | -86.37M | -62.91M | -0.87 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-28 | 개시 | Lake Street | Buy |
| 2024-02-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-06-15 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-05-24 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-11-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-08-10 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-01-10 | 개시 | SVB Leerink | Outperform |
| 2019-08-26 | 재개 | Credit Suisse | Outperform |
| 2019-05-02 | 개시 | Credit Suisse | Outperform |
| 2019-04-17 | 개시 | Oppenheimer | Outperform |
| 2019-04-11 | 개시 | SunTrust | Buy |
모두보기
Organogenesis Holdings Inc 주식(ORGO)의 최신 뉴스
Organogenesis Holdings: Solid Finances Protect From Uncertain Environment (NASDAQ:ORGO) - Seeking Alpha
Organogenesis (NASDAQ:ORGO) Stock Price Down 2.1% – What’s Next? - Defense World
Analyzing Organogenesis (NASDAQ:ORGO) and OnKure Therapeutics (NASDAQ:OKUR) - Defense World
Rhumbline Advisers Acquires 7,621 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Morgan Stanley Increases Organogenesis (NASDAQ:ORGO) Price Target to $6.00 - Defense World
Organogenesis director Michael Driscoll sells $127,535 in stock By Investing.com - Investing.com South Africa
Organogenesis director Michael Driscoll sells $127,535 in stock - Investing.com India
High Growth Stocks Insiders Are Eager To Own - Simply Wall St
Organogenesis (NASDAQ:ORGO) Trading 9.1% Higher on Analyst Upgrade - Defense World
Organogenesis Holdings Reports Strong Q4 Earnings Amid Challenges - TipRanks
Best Growth Stocks To Watch Now – March 1st - Defense World
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ORGO, MARA and OSH - ACCESS Newswire
Best Small Cap Stocks To Follow NowMarch 2nd - MarketBeat
Small Cap Stocks To Keep An Eye OnMarch 1st - MarketBeat
Best Growth Stocks To Watch NowMarch 1st - MarketBeat
There's No Escaping Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Muted Revenues Despite A 69% Share Price Rise - Simply Wall St
Organogenesis (NASDAQ:ORGO) Sets New 52-Week High – Here’s What Happened - Defense World
Promising Growth Stocks To ConsiderFebruary 28th - MarketBeat
ORGO stock touches 52-week high at $4.64 amid market fluctuations By Investing.com - Investing.com South Africa
CGI Inc. (GIB) Stock Forecasts - Yahoo Finance
Organogenesis (NASDAQ:ORGO) Issues Earnings Results - MarketBeat
United States shares higher at close of trade; Dow Jones Industrial Average up 1.39% - Investing.com India
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.39% - Investing.com
ORGO stock touches 52-week high at $4.64 amid market fluctuations - Investing.com
Today’s top stories: pain management innovation and revenue jumps - RagingBull
Cantor Fitzgerald lifts Organogenesis price target to $6.00 By Investing.com - Investing.com Canada
Cantor Fitzgerald lifts Organogenesis price target to $6.00 - Investing.com
Pre-market Movers: BTAI, VRPX, DCGO, NBY... - RTTNews
Earnings call transcript: Organogenesis Q4 2024 sees earnings beat, stock surges - Investing.com India
VRPX Soars On MET Results, COLL Projects 16%-19% Revenue Growth In 2025, RPID Gains Momentum - RTTNews
Organogenesis stock surges on earnings beat, strong guidance By Investing.com - Investing.com South Africa
U.S. Acellular Dermal Matrices Market Projected To Witness Substantial Growth, 2025-2032: AbbVie Inc., Johnson - EIN News
Organogenesis: Q4 Earnings Snapshot - mySA
After-Market Rally: Organogenesis (ORGO) Stock Spikes On Earnings Beat - Stocks Telegraph
Organogenesis (ORGO) Q4 2024 Earnings Call Transcript - AOL
Organogenesis (ORGO) Q4 2024 Earnings Call Transcript - The Motley Fool
Organogenesis Holdings Reports Strong Q4 2024 Results - TipRanks
Organogenesis stock surges on earnings beat, strong guidance - Investing.com India
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2024 Earnings Call Transcript - Insider Monkey
Earnings call transcript: Organogenesis Q4 2024 sees earnings beat, stock surges By Investing.com - Investing.com South Africa
Organogenesis stock jumps 17% on Q4 report, outlook - MSN
Organogenesis Holdings Inc. Reports Fourth Quarter 2024 Financial Results - The Manila Times
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2024 Financial Results - The Manila Times
Can Organogenesis Maintain Momentum After Q4 Revenue Jumps 27% and Profit Rebounds? - StockTitan
U.S. Tissue Engineering Market Size to Hit USD 69.00 Billion by 203 - BioSpace
Starbucks is getting rid of these 13 drinks in March. Here's what to know - Yahoo
Organogenesis Holdings Inc expected to post a loss of 1 cent a shareEarnings Preview - TradingView
Advancements In Bioink Technology For Tissue Engineering : Key Trend Transformation in the Cell Regeneratio... - WhaTech
Asia Pacific Wound Care Biologics Market Generated - openPR
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Organogenesis Holdings Inc. a Class Action Lawsuit and a Lead Plaintiff Deadline of February 8, 2022ORGO - ACCESS Newswire
Organogenesis (ORGO) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Organogenesis Holdings Inc (ORGO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Organogenesis Holdings Inc 주식 (ORGO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Driscoll Michael Joseph | Director |
Mar 04 '25 |
Sale |
5.10 |
25,000 |
127,535 |
166,879 |
| Gillheeney Gary S. | President and CEO |
Dec 13 '24 |
Sale |
3.36 |
55,615 |
186,866 |
3,044,779 |
| Gillheeney Gary S. | President and CEO |
Dec 16 '24 |
Sale |
3.49 |
5,585 |
19,492 |
3,039,194 |
| Gillheeney Gary S. | President and CEO |
Dec 11 '24 |
Sale |
3.64 |
157,448 |
573,111 |
3,143,753 |
| Gillheeney Gary S. | President and CEO |
Dec 10 '24 |
Sale |
3.64 |
58,525 |
213,031 |
3,301,201 |
| Gillheeney Gary S. | President and CEO |
Dec 12 '24 |
Sale |
3.55 |
43,359 |
153,924 |
3,100,394 |
| Gillheeney Gary S. | President and CEO |
Dec 05 '24 |
Option Exercise |
0.99 |
1,067,245 |
1,056,573 |
3,419,194 |
| Gillheeney Gary S. | President and CEO |
Dec 09 '24 |
Sale |
3.52 |
41,052 |
144,503 |
3,359,726 |
| Gillheeney Gary S. | President and CEO |
Dec 06 '24 |
Sale |
3.65 |
18,416 |
67,218 |
3,400,778 |
0.69%
0.06%
자본화:
|
볼륨(24시간):